Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-21-025611
Filing Date
2021-12-27
Accepted
2021-12-27 17:02:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B5 a424b5filing-prospectussup.htm 424B5 285690
  Complete submission text file 0001628280-21-025611.txt   286656
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-251308 | Film No.: 211521198
SIC: 2834 Pharmaceutical Preparations